The novel MyD88 inhibitor A5S ameliorates inflammation-driven diabetic cardiorenal complications
Fields of Study & Subjects
Chronic Kidney Disease and Diabetes
Cardiac Fibrosis and Remodeling
Advanced Glycation End Products research
Publication details
- Journal / source
- European Journal of Pharmacology
- Volume
- 1016
- Pages
- 178603–178603
- Publication date
- 28 January 2026
- Language
- EN